abnormal epidermis stratum corneum morphology, abnormal epidermis stratum granulosum morphology, abnormal fat cell morphology, abnormal food intake, abnormal hepatocyte morphology, abnormal lung development, abnormal professional antigen presenting cell physiology, abnormal seizure response to pharmacological agent, abnormal solitary pulmonary neuroendocrine cell morphology, abnormal surfactant composition, adrenal gland atrophy, decreased T cell proliferation, decreased adrenal gland weight, decreased anxiety-related response, decreased bone mineralization, decreased bone ossification, decreased circulating adrenaline level, decreased circulating osteocalcin level, decreased circulating parathyroid hormone level, decreased lean body mass, decreased osteoblast cell number, decreased susceptibility to experimental autoimmune encephalomyelitis, decreased susceptibility to neuronal excitotoxicity, homeostasis/metabolism phenotype, increased adrenal gland weight, increased anxiety-related response, increased circulating alanine transaminase level, increased circulating alkaline phosphatase level, increased circulating aspartate transaminase level, increased circulating creatinine level, increased circulating interleukin-6 level, increased mesenchymal cell proliferation involved in lung development, increased splenocyte number, increased total body fat amount, increased urine corticosterone level, maternal effect, nervous system phenotype, no abnormal phenotype detected, premature hair loss, thick pulmonary interalveolar septum, thin tail